Case report: Extraordinary clinical response to ibrutinib in low-grade ovarian cancer guided by organoid drug testing
Researchers associated with SEngine Precision Medicine, a precision oncology company that matches patients to medicines based on their own tumor samples, have published a new case report showing a patient's remarkable response ...
May 24, 2023
0
3